Alexander Alex – författare
Visar alla böcker från författaren Alexander Alex. Handla med fri frakt och snabb leverans.
3 produkter
3 produkter
Inbunden, Engelska, 2015
1 630 kr
Skickas inom 5-8 vardagar
With a focus on case studies of R&D programs in a variety of disease areas, the book highlights fundamental productivity issues the pharmaceutical industry has been facing and explores potential ways of improving research effectiveness and efficiency. Takes a comprehensive and holistic approach to the problems and potential solutions to drug compound attritionTackles a problem that adds billions of dollars to drug development programs and health care costsGuides discovery and development scientists through R&D stages, teaching requirements and reasons why drugs can failDiscusses potential ways forward utilizing new approaches and opportunities to reduce attrition
E-bok
PDF, Engelska, 20151 855 kr
Läs direkt efter köp
With a focus on case studies of R&D programs in a variety of disease areas, the book highlights fundamental productivity issues the pharmaceutical industry has been facing and explores potential ways of improving research effectiveness and efficiency.
Takes a comprehensive and holistic approach to the problems and potential solutions to drug compound attrition Tackles a problem that adds billions of dollars to drug development programs and health care costs Guides discovery and development scientists through R&D stages, teaching requirements and reasons why drugs can fail Discusses potential ways forward utilizing new approaches and opportunities to reduce attrition
E-bok
Engelska, 20151 823 kr
Läs direkt efter köp
With a focus on case studies of R&D programs in a variety of disease areas, the book highlights fundamental productivity issues the pharmaceutical industry has been facing and explores potential ways of improving research effectiveness and efficiency.
Takes a comprehensive and holistic approach to the problems and potential solutions to drug compound attrition Tackles a problem that adds billions of dollars to drug development programs and health care costs Guides discovery and development scientists through R&D stages, teaching requirements and reasons why drugs can fail Discusses potential ways forward utilizing new approaches and opportunities to reduce attrition